| Name | Main Street Apothecary |
|---|---|
| Organization Name | Patefield Enterprises Inc |
| Location | 201 E 2nd St, Laurel, Nebraska 68745 |
| Type | Pharmacy |
| Phone | (402) 256-3511 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The first study to analyze the complex ingredients in the new genre of dissolvable tobacco products has concluded that these pop-into-the-mouth replacements for cigarettes in places where smoking is banned have the potential to cause mouth diseases and other problems.
Watson Pharmaceuticals, Inc. today announced that it has entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion. Borrowings under the new term loan facility bear interest, at a rate equal to LIBOR plus an expected margin of 1.50%, which is subject to a ratings based margin grid. The new five year term loan is fully prepayable.
Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.
One of the most of the most widely used commercial chemicals to kill bedbugs are not effective because the pesky insects have built up a tolerance to them, according to a team of researchers from Virginia Tech and New Mexico State University.
› Verified 2 days ago
| NPI Number | 1912949793 |
| Organization Name | PATEFIELD ENTERPRISES INC |
| Doing Business As | MAIN ST APOTHECARY |
| Type | Pharmacy |
| Address | 201 E 2nd St, Laurel, NE 68745 |
| Phone Number | 402-256-3511 |
News Archive
The first study to analyze the complex ingredients in the new genre of dissolvable tobacco products has concluded that these pop-into-the-mouth replacements for cigarettes in places where smoking is banned have the potential to cause mouth diseases and other problems.
Watson Pharmaceuticals, Inc. today announced that it has entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion. Borrowings under the new term loan facility bear interest, at a rate equal to LIBOR plus an expected margin of 1.50%, which is subject to a ratings based margin grid. The new five year term loan is fully prepayable.
Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.
One of the most of the most widely used commercial chemicals to kill bedbugs are not effective because the pesky insects have built up a tolerance to them, according to a team of researchers from Virginia Tech and New Mexico State University.
› Verified 2 days ago
News Archive
The first study to analyze the complex ingredients in the new genre of dissolvable tobacco products has concluded that these pop-into-the-mouth replacements for cigarettes in places where smoking is banned have the potential to cause mouth diseases and other problems.
Watson Pharmaceuticals, Inc. today announced that it has entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion. Borrowings under the new term loan facility bear interest, at a rate equal to LIBOR plus an expected margin of 1.50%, which is subject to a ratings based margin grid. The new five year term loan is fully prepayable.
Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.
One of the most of the most widely used commercial chemicals to kill bedbugs are not effective because the pesky insects have built up a tolerance to them, according to a team of researchers from Virginia Tech and New Mexico State University.
› Verified 2 days ago
Main Street Apothecary Type: Pharmacy Location: 201 E 2nd St, Laurel, Nebraska 68745 Phone: (402) 256-3511 |